Nirma to buy majority stake in Glenmark Life Sciences

The transaction is subject to customary closing conditions precedent, including receipt of regulatory and shareholder approvals, added the release. Pursuant to the transaction, Nirma Limited will make a mandatory open offer to all public shareholders of GLS. The other contender Sekhmet Pharmaventures, a platform backed by, PAG, CX Partners and Samara Capital, did not put in their final offer after intense negotiations, ET reported.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/uCA3t8z
via IFTTT